Invention Grant
- Patent Title: Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
-
Application No.: US16254438Application Date: 2019-01-22
-
Publication No.: US10899780B2Publication Date: 2021-01-26
- Inventor: Richard L. Beard , John E. Donello , Veena Viswanath
- Applicant: ALLERGAN, INC.
- Applicant Address: US CA Irvine
- Assignee: ALLERGAN, INC.
- Current Assignee: ALLERGAN, INC.
- Current Assignee Address: US CA Irvine
- Agent Jonathan Bass
- Main IPC: A61K31/66
- IPC: A61K31/66 ; A61K31/554 ; A61K31/47 ; A61K31/42 ; A61K31/41 ; A61K31/415 ; C07F9/40 ; C07C235/82 ; C07C275/42 ; C07D217/24 ; C07D223/10 ; C07D233/02 ; C07D235/02 ; C07D257/04 ; C07D261/12 ; C07D401/06 ; C07D401/14 ; C07D403/14 ; C07D405/06 ; C07D409/06 ; A61K9/00 ; A61K31/17 ; A61K31/196 ; A61K31/4166 ; A61K31/662
Abstract:
The present invention relates to a method for treating ocular inflammatory diseases in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of at least one agonist of Formyl peptide receptor 2.
Public/Granted literature
- US20190153004A1 USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING OCULAR INFLAMMATORY DISEASES Public/Granted day:2019-05-23
Information query
